logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

ER+ male BCa: PR-negative status tied to poorer survival in SEER analysis

ER+/PR- male breast cancer is more aggressive than ER+/PR+ disease.